Global Rivaroxaban Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Rivaroxaban market size is predicted to grow from US$ 9146 million in 2025 to US$ 14930 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The major players in global Prom Dresses market include Bayer, Johnson and Johnson, etc. The top 2 players occupy nearly 100% of the market. Europe is the main market, and occupies nearly 100% of the global market. 10 mg is the main type, with a share over 30%. Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.
LP Information, Inc. (LPI) ' newest research report, the “Rivaroxaban Industry Forecast” looks at past sales and reviews total world Rivaroxaban sales in 2024, providing a comprehensive analysis by region and market sector of projected Rivaroxaban sales for 2025 through 2031. With Rivaroxaban sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rivaroxaban industry.
This Insight Report provides a comprehensive analysis of the global Rivaroxaban landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rivaroxaban portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rivaroxaban market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rivaroxaban and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rivaroxaban.
This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Rivaroxaban market?
What factors are driving Rivaroxaban market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rivaroxaban market opportunities vary by end market size?
How does Rivaroxaban break out by Type, by Application?
The global Rivaroxaban market size is predicted to grow from US$ 9146 million in 2025 to US$ 14930 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The major players in global Prom Dresses market include Bayer, Johnson and Johnson, etc. The top 2 players occupy nearly 100% of the market. Europe is the main market, and occupies nearly 100% of the global market. 10 mg is the main type, with a share over 30%. Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.
LP Information, Inc. (LPI) ' newest research report, the “Rivaroxaban Industry Forecast” looks at past sales and reviews total world Rivaroxaban sales in 2024, providing a comprehensive analysis by region and market sector of projected Rivaroxaban sales for 2025 through 2031. With Rivaroxaban sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rivaroxaban industry.
This Insight Report provides a comprehensive analysis of the global Rivaroxaban landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rivaroxaban portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rivaroxaban market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rivaroxaban and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rivaroxaban.
This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 2.5 mg
- 10 mg
- 15 mg
- 20 mg
- Acute Coronary Syndrome (ACS)
- Venous Thromboembolism (VTE)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- J&J
What is the 10-year outlook for the global Rivaroxaban market?
What factors are driving Rivaroxaban market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rivaroxaban market opportunities vary by end market size?
How does Rivaroxaban break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rivaroxaban Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Rivaroxaban by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Rivaroxaban by Country/Region, 2020, 2024 & 2031
2.2 Rivaroxaban Segment by Type
2.2.1 2.5 mg
2.2.2 10 mg
2.2.3 15 mg
2.2.4 20 mg
2.3 Rivaroxaban Sales by Type
2.3.1 Global Rivaroxaban Sales Market Share by Type (2020-2025)
2.3.2 Global Rivaroxaban Revenue and Market Share by Type (2020-2025)
2.3.3 Global Rivaroxaban Sale Price by Type (2020-2025)
2.4 Rivaroxaban Segment by Application
2.4.1 Acute Coronary Syndrome (ACS)
2.4.2 Venous Thromboembolism (VTE)
2.5 Rivaroxaban Sales by Application
2.5.1 Global Rivaroxaban Sale Market Share by Application (2020-2025)
2.5.2 Global Rivaroxaban Revenue and Market Share by Application (2020-2025)
2.5.3 Global Rivaroxaban Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Rivaroxaban Breakdown Data by Company
3.1.1 Global Rivaroxaban Annual Sales by Company (2020-2025)
3.1.2 Global Rivaroxaban Sales Market Share by Company (2020-2025)
3.2 Global Rivaroxaban Annual Revenue by Company (2020-2025)
3.2.1 Global Rivaroxaban Revenue by Company (2020-2025)
3.2.2 Global Rivaroxaban Revenue Market Share by Company (2020-2025)
3.3 Global Rivaroxaban Sale Price by Company
3.4 Key Manufacturers Rivaroxaban Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rivaroxaban Product Location Distribution
3.4.2 Players Rivaroxaban Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RIVAROXABAN BY GEOGRAPHIC REGION
4.1 World Historic Rivaroxaban Market Size by Geographic Region (2020-2025)
4.1.1 Global Rivaroxaban Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Rivaroxaban Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Rivaroxaban Market Size by Country/Region (2020-2025)
4.2.1 Global Rivaroxaban Annual Sales by Country/Region (2020-2025)
4.2.2 Global Rivaroxaban Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rivaroxaban Sales Growth
4.4 APAC Rivaroxaban Sales Growth
4.5 Europe Rivaroxaban Sales Growth
4.6 Middle East & Africa Rivaroxaban Sales Growth
5 AMERICAS
5.1 Americas Rivaroxaban Sales by Country
5.1.1 Americas Rivaroxaban Sales by Country (2020-2025)
5.1.2 Americas Rivaroxaban Revenue by Country (2020-2025)
5.2 Americas Rivaroxaban Sales by Type (2020-2025)
5.3 Americas Rivaroxaban Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rivaroxaban Sales by Region
6.1.1 APAC Rivaroxaban Sales by Region (2020-2025)
6.1.2 APAC Rivaroxaban Revenue by Region (2020-2025)
6.2 APAC Rivaroxaban Sales by Type (2020-2025)
6.3 APAC Rivaroxaban Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rivaroxaban by Country
7.1.1 Europe Rivaroxaban Sales by Country (2020-2025)
7.1.2 Europe Rivaroxaban Revenue by Country (2020-2025)
7.2 Europe Rivaroxaban Sales by Type (2020-2025)
7.3 Europe Rivaroxaban Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rivaroxaban by Country
8.1.1 Middle East & Africa Rivaroxaban Sales by Country (2020-2025)
8.1.2 Middle East & Africa Rivaroxaban Revenue by Country (2020-2025)
8.2 Middle East & Africa Rivaroxaban Sales by Type (2020-2025)
8.3 Middle East & Africa Rivaroxaban Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rivaroxaban
10.3 Manufacturing Process Analysis of Rivaroxaban
10.4 Industry Chain Structure of Rivaroxaban
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rivaroxaban Distributors
11.3 Rivaroxaban Customer
12 WORLD FORECAST REVIEW FOR RIVAROXABAN BY GEOGRAPHIC REGION
12.1 Global Rivaroxaban Market Size Forecast by Region
12.1.1 Global Rivaroxaban Forecast by Region (2026-2031)
12.1.2 Global Rivaroxaban Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Rivaroxaban Forecast by Type (2026-2031)
12.7 Global Rivaroxaban Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Rivaroxaban Product Portfolios and Specifications
13.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 J&J
13.2.1 J&J Company Information
13.2.2 J&J Rivaroxaban Product Portfolios and Specifications
13.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 J&J Main Business Overview
13.2.5 J&J Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rivaroxaban Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Rivaroxaban by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Rivaroxaban by Country/Region, 2020, 2024 & 2031
2.2 Rivaroxaban Segment by Type
2.2.1 2.5 mg
2.2.2 10 mg
2.2.3 15 mg
2.2.4 20 mg
2.3 Rivaroxaban Sales by Type
2.3.1 Global Rivaroxaban Sales Market Share by Type (2020-2025)
2.3.2 Global Rivaroxaban Revenue and Market Share by Type (2020-2025)
2.3.3 Global Rivaroxaban Sale Price by Type (2020-2025)
2.4 Rivaroxaban Segment by Application
2.4.1 Acute Coronary Syndrome (ACS)
2.4.2 Venous Thromboembolism (VTE)
2.5 Rivaroxaban Sales by Application
2.5.1 Global Rivaroxaban Sale Market Share by Application (2020-2025)
2.5.2 Global Rivaroxaban Revenue and Market Share by Application (2020-2025)
2.5.3 Global Rivaroxaban Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Rivaroxaban Breakdown Data by Company
3.1.1 Global Rivaroxaban Annual Sales by Company (2020-2025)
3.1.2 Global Rivaroxaban Sales Market Share by Company (2020-2025)
3.2 Global Rivaroxaban Annual Revenue by Company (2020-2025)
3.2.1 Global Rivaroxaban Revenue by Company (2020-2025)
3.2.2 Global Rivaroxaban Revenue Market Share by Company (2020-2025)
3.3 Global Rivaroxaban Sale Price by Company
3.4 Key Manufacturers Rivaroxaban Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rivaroxaban Product Location Distribution
3.4.2 Players Rivaroxaban Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RIVAROXABAN BY GEOGRAPHIC REGION
4.1 World Historic Rivaroxaban Market Size by Geographic Region (2020-2025)
4.1.1 Global Rivaroxaban Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Rivaroxaban Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Rivaroxaban Market Size by Country/Region (2020-2025)
4.2.1 Global Rivaroxaban Annual Sales by Country/Region (2020-2025)
4.2.2 Global Rivaroxaban Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rivaroxaban Sales Growth
4.4 APAC Rivaroxaban Sales Growth
4.5 Europe Rivaroxaban Sales Growth
4.6 Middle East & Africa Rivaroxaban Sales Growth
5 AMERICAS
5.1 Americas Rivaroxaban Sales by Country
5.1.1 Americas Rivaroxaban Sales by Country (2020-2025)
5.1.2 Americas Rivaroxaban Revenue by Country (2020-2025)
5.2 Americas Rivaroxaban Sales by Type (2020-2025)
5.3 Americas Rivaroxaban Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rivaroxaban Sales by Region
6.1.1 APAC Rivaroxaban Sales by Region (2020-2025)
6.1.2 APAC Rivaroxaban Revenue by Region (2020-2025)
6.2 APAC Rivaroxaban Sales by Type (2020-2025)
6.3 APAC Rivaroxaban Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rivaroxaban by Country
7.1.1 Europe Rivaroxaban Sales by Country (2020-2025)
7.1.2 Europe Rivaroxaban Revenue by Country (2020-2025)
7.2 Europe Rivaroxaban Sales by Type (2020-2025)
7.3 Europe Rivaroxaban Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rivaroxaban by Country
8.1.1 Middle East & Africa Rivaroxaban Sales by Country (2020-2025)
8.1.2 Middle East & Africa Rivaroxaban Revenue by Country (2020-2025)
8.2 Middle East & Africa Rivaroxaban Sales by Type (2020-2025)
8.3 Middle East & Africa Rivaroxaban Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rivaroxaban
10.3 Manufacturing Process Analysis of Rivaroxaban
10.4 Industry Chain Structure of Rivaroxaban
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rivaroxaban Distributors
11.3 Rivaroxaban Customer
12 WORLD FORECAST REVIEW FOR RIVAROXABAN BY GEOGRAPHIC REGION
12.1 Global Rivaroxaban Market Size Forecast by Region
12.1.1 Global Rivaroxaban Forecast by Region (2026-2031)
12.1.2 Global Rivaroxaban Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Rivaroxaban Forecast by Type (2026-2031)
12.7 Global Rivaroxaban Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Rivaroxaban Product Portfolios and Specifications
13.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 J&J
13.2.1 J&J Company Information
13.2.2 J&J Rivaroxaban Product Portfolios and Specifications
13.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 J&J Main Business Overview
13.2.5 J&J Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rivaroxaban Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Rivaroxaban Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 2.5 mg
Table 4. Major Players of 10 mg
Table 5. Major Players of 15 mg
Table 6. Major Players of 20 mg
Table 7. Global Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 8. Global Rivaroxaban Sales Market Share byType (2020-2025)
Table 9. Global Rivaroxaban Revenue byType (2020-2025) & ($ million)
Table 10. Global Rivaroxaban Revenue Market Share byType (2020-2025)
Table 11. Global Rivaroxaban Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Rivaroxaban Sale by Application (2020-2025) & (K Units)
Table 13. Global Rivaroxaban Sale Market Share by Application (2020-2025)
Table 14. Global Rivaroxaban Revenue by Application (2020-2025) & ($ million)
Table 15. Global Rivaroxaban Revenue Market Share by Application (2020-2025)
Table 16. Global Rivaroxaban Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Rivaroxaban Sales by Company (2020-2025) & (K Units)
Table 18. Global Rivaroxaban Sales Market Share by Company (2020-2025)
Table 19. Global Rivaroxaban Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Rivaroxaban Revenue Market Share by Company (2020-2025)
Table 21. Global Rivaroxaban Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Rivaroxaban Producing Area Distribution and Sales Area
Table 23. Players Rivaroxaban Products Offered
Table 24. Rivaroxaban Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Rivaroxaban Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Rivaroxaban Sales Market Share Geographic Region (2020-2025)
Table 29. Global Rivaroxaban Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Rivaroxaban Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Rivaroxaban Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Rivaroxaban Sales Market Share by Country/Region (2020-2025)
Table 33. Global Rivaroxaban Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Rivaroxaban Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 36. Americas Rivaroxaban Sales Market Share by Country (2020-2025)
Table 37. Americas Rivaroxaban Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 39. Americas Rivaroxaban Sales by Application (2020-2025) & (K Units)
Table 40. APAC Rivaroxaban Sales by Region (2020-2025) & (K Units)
Table 41. APAC Rivaroxaban Sales Market Share by Region (2020-2025)
Table 42. APAC Rivaroxaban Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 44. APAC Rivaroxaban Sales by Application (2020-2025) & (K Units)
Table 45. Europe Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 46. Europe Rivaroxaban Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 48. Europe Rivaroxaban Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Rivaroxaban Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Rivaroxaban Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Rivaroxaban
Table 54. Key Market Challenges & Risks of Rivaroxaban
Table 55. Key IndustryTrends of Rivaroxaban
Table 56. Rivaroxaban Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Rivaroxaban Distributors List
Table 59. Rivaroxaban Customer List
Table 60. Global Rivaroxaban SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Rivaroxaban RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Rivaroxaban SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Rivaroxaban Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Rivaroxaban SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Rivaroxaban Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Rivaroxaban SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Rivaroxaban RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Rivaroxaban SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Rivaroxaban RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Rivaroxaban SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Rivaroxaban RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Rivaroxaban SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Rivaroxaban RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Bayer Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
Table 75. Bayer Rivaroxaban Product Portfolios and Specifications
Table 76. Bayer Rivaroxaban Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bayer Main Business
Table 78. Bayer Latest Developments
Table 79. J&J Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
Table 80. J&J Rivaroxaban Product Portfolios and Specifications
Table 81. J&J Rivaroxaban Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. J&J Main Business
Table 83. J&J Latest Developments
Table 1. Rivaroxaban Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Rivaroxaban Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 2.5 mg
Table 4. Major Players of 10 mg
Table 5. Major Players of 15 mg
Table 6. Major Players of 20 mg
Table 7. Global Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 8. Global Rivaroxaban Sales Market Share byType (2020-2025)
Table 9. Global Rivaroxaban Revenue byType (2020-2025) & ($ million)
Table 10. Global Rivaroxaban Revenue Market Share byType (2020-2025)
Table 11. Global Rivaroxaban Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Rivaroxaban Sale by Application (2020-2025) & (K Units)
Table 13. Global Rivaroxaban Sale Market Share by Application (2020-2025)
Table 14. Global Rivaroxaban Revenue by Application (2020-2025) & ($ million)
Table 15. Global Rivaroxaban Revenue Market Share by Application (2020-2025)
Table 16. Global Rivaroxaban Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Rivaroxaban Sales by Company (2020-2025) & (K Units)
Table 18. Global Rivaroxaban Sales Market Share by Company (2020-2025)
Table 19. Global Rivaroxaban Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Rivaroxaban Revenue Market Share by Company (2020-2025)
Table 21. Global Rivaroxaban Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Rivaroxaban Producing Area Distribution and Sales Area
Table 23. Players Rivaroxaban Products Offered
Table 24. Rivaroxaban Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Rivaroxaban Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Rivaroxaban Sales Market Share Geographic Region (2020-2025)
Table 29. Global Rivaroxaban Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Rivaroxaban Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Rivaroxaban Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Rivaroxaban Sales Market Share by Country/Region (2020-2025)
Table 33. Global Rivaroxaban Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Rivaroxaban Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 36. Americas Rivaroxaban Sales Market Share by Country (2020-2025)
Table 37. Americas Rivaroxaban Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 39. Americas Rivaroxaban Sales by Application (2020-2025) & (K Units)
Table 40. APAC Rivaroxaban Sales by Region (2020-2025) & (K Units)
Table 41. APAC Rivaroxaban Sales Market Share by Region (2020-2025)
Table 42. APAC Rivaroxaban Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 44. APAC Rivaroxaban Sales by Application (2020-2025) & (K Units)
Table 45. Europe Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 46. Europe Rivaroxaban Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 48. Europe Rivaroxaban Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Rivaroxaban Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Rivaroxaban Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Rivaroxaban Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Rivaroxaban
Table 54. Key Market Challenges & Risks of Rivaroxaban
Table 55. Key IndustryTrends of Rivaroxaban
Table 56. Rivaroxaban Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Rivaroxaban Distributors List
Table 59. Rivaroxaban Customer List
Table 60. Global Rivaroxaban SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Rivaroxaban RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Rivaroxaban SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Rivaroxaban Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Rivaroxaban SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Rivaroxaban Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Rivaroxaban SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Rivaroxaban RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Rivaroxaban SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Rivaroxaban RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Rivaroxaban SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Rivaroxaban RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Rivaroxaban SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Rivaroxaban RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Bayer Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
Table 75. Bayer Rivaroxaban Product Portfolios and Specifications
Table 76. Bayer Rivaroxaban Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bayer Main Business
Table 78. Bayer Latest Developments
Table 79. J&J Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
Table 80. J&J Rivaroxaban Product Portfolios and Specifications
Table 81. J&J Rivaroxaban Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. J&J Main Business
Table 83. J&J Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rivaroxaban
Figure 2. Rivaroxaban Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rivaroxaban Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Rivaroxaban Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Rivaroxaban Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Rivaroxaban Sales Market Share by Country/Region (2024)
Figure 10. Rivaroxaban Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 2.5 mg
Figure 12. Product Picture of 10 mg
Figure 13. Product Picture of 15 mg
Figure 14. Product Picture of 20 mg
Figure 15. Global Rivaroxaban Sales Market Share byType in 2025
Figure 16. Global Rivaroxaban Revenue Market Share byType (2020-2025)
Figure 17. Rivaroxaban Consumed in Acute Coronary Syndrome (ACS)
Figure 18. Global Rivaroxaban Market: Acute Coronary Syndrome (ACS) (2020-2025) & (K Units)
Figure 19. Rivaroxaban Consumed in VenousThromboembolism (VTE)
Figure 20. Global Rivaroxaban Market: VenousThromboembolism (VTE) (2020-2025) & (K Units)
Figure 21. Global Rivaroxaban Sale Market Share by Application (2024)
Figure 22. Global Rivaroxaban Revenue Market Share by Application in 2025
Figure 23. Rivaroxaban Sales by Company in 2025 (K Units)
Figure 24. Global Rivaroxaban Sales Market Share by Company in 2025
Figure 25. Rivaroxaban Revenue by Company in 2025 ($ millions)
Figure 26. Global Rivaroxaban Revenue Market Share by Company in 2025
Figure 27. Global Rivaroxaban Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Rivaroxaban Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Rivaroxaban Sales 2020-2025 (K Units)
Figure 30. Americas Rivaroxaban Revenue 2020-2025 ($ millions)
Figure 31. APAC Rivaroxaban Sales 2020-2025 (K Units)
Figure 32. APAC Rivaroxaban Revenue 2020-2025 ($ millions)
Figure 33. Europe Rivaroxaban Sales 2020-2025 (K Units)
Figure 34. Europe Rivaroxaban Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Rivaroxaban Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Rivaroxaban Revenue 2020-2025 ($ millions)
Figure 37. Americas Rivaroxaban Sales Market Share by Country in 2025
Figure 38. Americas Rivaroxaban Revenue Market Share by Country (2020-2025)
Figure 39. Americas Rivaroxaban Sales Market Share byType (2020-2025)
Figure 40. Americas Rivaroxaban Sales Market Share by Application (2020-2025)
Figure 41. United States Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Rivaroxaban Sales Market Share by Region in 2025
Figure 46. APAC Rivaroxaban Revenue Market Share by Region (2020-2025)
Figure 47. APAC Rivaroxaban Sales Market Share byType (2020-2025)
Figure 48. APAC Rivaroxaban Sales Market Share by Application (2020-2025)
Figure 49. China Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 53. India Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Rivaroxaban Sales Market Share by Country in 2025
Figure 57. Europe Rivaroxaban Revenue Market Share by Country (2020-2025)
Figure 58. Europe Rivaroxaban Sales Market Share byType (2020-2025)
Figure 59. Europe Rivaroxaban Sales Market Share by Application (2020-2025)
Figure 60. Germany Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 61.France Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Rivaroxaban Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Rivaroxaban Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Rivaroxaban Sales Market Share by Application (2020-2025)
Figure 68. Egypt Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Rivaroxaban in 2025
Figure 74. Manufacturing Process Analysis of Rivaroxaban
Figure 75. Industry Chain Structure of Rivaroxaban
Figure 76. Channels of Distribution
Figure 77. Global Rivaroxaban Sales MarketForecast by Region (2026-2031)
Figure 78. Global Rivaroxaban Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Rivaroxaban Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Rivaroxaban Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Rivaroxaban Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Rivaroxaban Revenue Market ShareForecast by Application (2026-2031)
Figure 1. Picture of Rivaroxaban
Figure 2. Rivaroxaban Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rivaroxaban Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Rivaroxaban Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Rivaroxaban Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Rivaroxaban Sales Market Share by Country/Region (2024)
Figure 10. Rivaroxaban Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 2.5 mg
Figure 12. Product Picture of 10 mg
Figure 13. Product Picture of 15 mg
Figure 14. Product Picture of 20 mg
Figure 15. Global Rivaroxaban Sales Market Share byType in 2025
Figure 16. Global Rivaroxaban Revenue Market Share byType (2020-2025)
Figure 17. Rivaroxaban Consumed in Acute Coronary Syndrome (ACS)
Figure 18. Global Rivaroxaban Market: Acute Coronary Syndrome (ACS) (2020-2025) & (K Units)
Figure 19. Rivaroxaban Consumed in VenousThromboembolism (VTE)
Figure 20. Global Rivaroxaban Market: VenousThromboembolism (VTE) (2020-2025) & (K Units)
Figure 21. Global Rivaroxaban Sale Market Share by Application (2024)
Figure 22. Global Rivaroxaban Revenue Market Share by Application in 2025
Figure 23. Rivaroxaban Sales by Company in 2025 (K Units)
Figure 24. Global Rivaroxaban Sales Market Share by Company in 2025
Figure 25. Rivaroxaban Revenue by Company in 2025 ($ millions)
Figure 26. Global Rivaroxaban Revenue Market Share by Company in 2025
Figure 27. Global Rivaroxaban Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Rivaroxaban Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Rivaroxaban Sales 2020-2025 (K Units)
Figure 30. Americas Rivaroxaban Revenue 2020-2025 ($ millions)
Figure 31. APAC Rivaroxaban Sales 2020-2025 (K Units)
Figure 32. APAC Rivaroxaban Revenue 2020-2025 ($ millions)
Figure 33. Europe Rivaroxaban Sales 2020-2025 (K Units)
Figure 34. Europe Rivaroxaban Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Rivaroxaban Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Rivaroxaban Revenue 2020-2025 ($ millions)
Figure 37. Americas Rivaroxaban Sales Market Share by Country in 2025
Figure 38. Americas Rivaroxaban Revenue Market Share by Country (2020-2025)
Figure 39. Americas Rivaroxaban Sales Market Share byType (2020-2025)
Figure 40. Americas Rivaroxaban Sales Market Share by Application (2020-2025)
Figure 41. United States Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Rivaroxaban Sales Market Share by Region in 2025
Figure 46. APAC Rivaroxaban Revenue Market Share by Region (2020-2025)
Figure 47. APAC Rivaroxaban Sales Market Share byType (2020-2025)
Figure 48. APAC Rivaroxaban Sales Market Share by Application (2020-2025)
Figure 49. China Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 53. India Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Rivaroxaban Sales Market Share by Country in 2025
Figure 57. Europe Rivaroxaban Revenue Market Share by Country (2020-2025)
Figure 58. Europe Rivaroxaban Sales Market Share byType (2020-2025)
Figure 59. Europe Rivaroxaban Sales Market Share by Application (2020-2025)
Figure 60. Germany Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 61.France Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Rivaroxaban Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Rivaroxaban Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Rivaroxaban Sales Market Share by Application (2020-2025)
Figure 68. Egypt Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Rivaroxaban Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Rivaroxaban in 2025
Figure 74. Manufacturing Process Analysis of Rivaroxaban
Figure 75. Industry Chain Structure of Rivaroxaban
Figure 76. Channels of Distribution
Figure 77. Global Rivaroxaban Sales MarketForecast by Region (2026-2031)
Figure 78. Global Rivaroxaban Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Rivaroxaban Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Rivaroxaban Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Rivaroxaban Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Rivaroxaban Revenue Market ShareForecast by Application (2026-2031)
